Our Commitment to Diabetes Research

We reinvest a significant part of our annual sales into the research and development of new products that can support the daily management of diabetes. Specifically, we target greater accuracy and compliance with therapies. That's because our goal is to offer people with diabetes, as well as their families and healthcare providers, a wide range of treatment options and services.

Responding to the existing and future needs of people with diabetes, Novo Nordisk scientists work diligently to discover new chemical compounds and therapeutic agents. Our edge in scientific discovery makes us uniquely poised to address the issues at the very core of the diabetes epidemic: insulin deficiency and the complexities of treating it.